JSK THERAPEUTICS, INC.

Profile

Company Names

JSK THERAPEUTICS, INC.

Addresses

9758 CERVANTES CIRCLE, SANDY, UT 84092

Phone Numbers

801-971-6678

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$962,839.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2017-11-27 
$962,839.00 
$1,012,835.00 
$49,996.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DR. JOSEPH 
 
NOWOSLAWSKI 
EXECUTIVE OFFICER, DIRECTOR
JSK THERAPEUTICS, INC.
JASON 
 
OCKEY 
DIRECTOR
JSK THERAPEUTICS, INC.   |  TAVA HEALTH, INC.
DINESH 
 
PATEL 
DIRECTOR
ALTA GROWTH CAPITAL MEXICO FEEDER FUND I LP   |  ALTA GROWTH CAPITAL MEXICO FUND LP   |  EXAGEN DIAGNOSTICS INC   |  MIRABILIS MEDICA INC   |  NUMIRA BIOSCIENCES INC   |  ATHENA FEMININE TECHNOLOGIES, INC.   |  VSPRING II GROWTH FUND LP   |  VSPRING PARTNERS III, L.P.   |  AMERICAN ACADEMY INC   |  VSPRING III (SP) LP   |  LINEAGEN INC   |  JUNEAU BIOSCIENCES, LLC   |  TUTE GENOMICS, INC.   |  PRIMARY CARE PARTNERS, LLC   |  JSK THERAPEUTICS, INC.   |  EKA SOLUTIONS, INC.   |  SECOND HEART ASSIST, INC.   |  XENOCOR, INC.   |  APPLIED BIOSENSORS, INC.\DE
RANDALL 
 
PETERSON 
DIRECTOR
JSK THERAPEUTICS, INC.
PAUL 
 
SHAMI 
EXECUTIVE OFFICER, DIRECTOR
JSK THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-12-12
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#